Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 32%.
- Their past buys: 5 of 6 beat the S&P 500 over 90 days.
Reasons for caution
- Other insiders sold $4.5M in the same 90 days, more than was bought.
- Similar past buys beat the S&P 500 only 47% of the time (122 cases); the typical one trailed it by 1.5%.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $250K–$1M · stock down 0–20% in 3 months
SEI Sep 9, 2025 +110.5% vs S&PNVCT Dec 26, 2024 +79.5% vs S&PCVRX Aug 15, 2024 +69.0% vs S&PNRSN Jun 17, 2026 -52.6% vs S&PNEOG Jan 16, 2025 -49.5% vs S&POPFI May 23, 2022 -36.1% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Nicos Katsoulis (a director) bought $178K of OCFC at about $17.83 on Oct 30, 2026, reported to the SEC on Nov 2, 2026. Buys like this beat the S&P 500 47% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the OCFC alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.